Fusion event
HBV-chr2 integration
Disease
Hepatocellular carcinoma (HCC)
Quality evaluation
Normal
Integrated sequence
CCGACCTTGAGGCATACTTCAAAGACTGTTTGTTTAAAGACTGGGAGGAGTTGGGGGAGGAGATTAGGTTAAAGGTCTTTGTACTAGGAGGCTGTAGGCA| |TAAATTGGTCTGCGCACCAGCACCATGCAACTTTTTCACCTCTGCCTAATCATCTCTTGTTCATGTCCTACTGTTCAAGCCTCCAAGCTGTGCCTTGGGT
End
25923001/25700132 (Hg38)
Nearest miRNA
hsa-mir-1301/Upstream/371411; hsa-mir-10b/Downstream/2296235;
Upstream sequence
aaaaaaattgtggtaaaatatatatacataaaatttatcattgtaaccatttttatgtgtgcagttcagtggcatgaattagattcatattgctgtgcag
Downstream sequence
ccatcaccaccatccatccccagaacttttccatcatccgcagatgaaatgttgtatcccttgaataataaccgcccatttctttgcctcccATGCCCTT
Yang, L., et al. Molecular Characterization of HBV DNA Integration in Patients with Hepatitis and Hepatocellular Carcinoma. J Cancer ,2018,9(18): 3225-3235.